搜索
Janux Therapeutics Inc
JANX添加自选
14.220USD
+0.070+0.49%
收盘 06/18, 16:00（美东）报价延迟15分钟
867.20M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
18.35%
Janus Henderson Investors
8.77%
BlackRock Institutional Trust Company, N.A.
5.64%
Prosight Capital
5.17%
Point72 Asset Management, L.P.
5.03%
其他
57.04%
持股股东
持股股东
占比
RA Capital Management, LP
18.35%
Janus Henderson Investors
8.77%
BlackRock Institutional Trust Company, N.A.
5.64%
Prosight Capital
5.17%
Point72 Asset Management, L.P.
5.03%
其他
57.04%
股东类型
持股股东
占比
Investment Advisor
26.65%
Investment Advisor/Hedge Fund
26.24%
Hedge Fund
25.87%
Venture Capital
20.34%
Corporation
4.92%
Research Firm
4.90%
Private Equity
3.20%
Individual Investor
1.93%
Pension Fund
0.86%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
461
67.20M
110.21%
-10.28M
2025Q4
428
65.86M
109.50%
-9.23M
2025Q3
405
67.14M
111.63%
-9.60M
2025Q2
406
71.98M
121.61%
-4.34M
2025Q1
413
73.50M
124.27%
-3.92M
2024Q4
403
71.29M
120.67%
+11.65M
2024Q3
335
56.66M
107.54%
-2.86M
2024Q2
298
57.26M
111.36%
+52.19K
2024Q1
242
56.34M
109.98%
+6.39M
2023Q4
179
48.33M
104.72%
-1.60M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
11.19M
18.39%
--
--
Dec 31, 2025
Janus Henderson Investors
5.35M
8.8%
+649.34K
+13.81%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.44M
5.65%
+223.39K
+6.95%
Dec 31, 2025
Prosight Capital
3.15M
5.18%
+758.45K
+31.70%
Feb 03, 2026
Point72 Asset Management, L.P.
961.82K
1.58%
-748.38K
-43.76%
Dec 31, 2025
Bregua Corp
3.00M
4.93%
-830.27K
-21.68%
Sep 30, 2024
State Street Investment Management (US)
3.85M
6.34%
+1.96M
+103.75%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.33M
3.83%
-6.12M
-72.43%
Dec 31, 2025
OrbiMed Advisors, LLC
1.95M
3.21%
+188.33K
+10.66%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Genomics Immunology and Healthcare ETF
3.02%
Tema Oncology ETF
1.82%
Virtus LifeSci Biotech Clinical Trials ETF
0.76%
State Street SPDR S&P Biotech ETF
0.53%
Direxion Daily S&P Biotech Bull 3X Shares
0.33%
ProShares Ultra Nasdaq Biotechnology
0.25%
Invesco Nasdaq Biotechnology ETF
0.17%
iShares Biotechnology ETF
0.14%
T Rowe Price Small-Mid Cap ETF
0.09%
Pacer WealthShield ETF
0.08%
查看更多
iShares Genomics Immunology and Healthcare ETF
占比3.02%
Tema Oncology ETF
占比1.82%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.76%
State Street SPDR S&P Biotech ETF
占比0.53%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.33%
ProShares Ultra Nasdaq Biotechnology
占比0.25%
Invesco Nasdaq Biotechnology ETF
占比0.17%
iShares Biotechnology ETF
占比0.14%
T Rowe Price Small-Mid Cap ETF
占比0.09%
Pacer WealthShield ETF
占比0.08%
